PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsUS company offers parents home testing for inheritable genetic diseases

BioNews

US company offers parents home testing for inheritable genetic diseases

Published 1 February 2010 posted in News and appears in BioNews 543

Author

Dr Nadeem Shaikh

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A company in the US is offering potential parents the chance to test whether their future offspring might develop serious health problems by selling them home genetic test kits. Counsyl allows customers to send a saliva sample via the post, which is used in conjunction with DNA chip technology to screen if the person is a carrier for a single genetic mutation known to cause a disease. If both parents carry the same mutation,...

A company in the US is offering potential parents the chance to test whether their future offspring might develop serious health problems by selling them home genetic test kits. The company Counsyl allows customers to send a saliva sample via the post, which is used in conjunction with DNA chip technology to screen if the person is a carrier for a single genetic mutation known to cause a disease. If both parents carry the same mutation, there is a one in four chance that any child they conceive will develop the disease.


The test checks for diseases such as cystic fibrosis, Tay-Sachs or sickle cell anaemia. If the couple is found to be at risk of passing such traits onto their children, steps can be taken to prevent this, such as using genetic screening of embryos to which are implanted for IVF. The company stated that 35-40 per cent of couples tested were carriers for at least one condition, and in 0.6-0.8 per cent of the cases, both parents in the couple were found to be carriers for the same genetic mutation.


Genetic tests are already carried out by hospitals, but only for a few of the more common conditions, and they often cost a lot of money. Counsyl offers its test for over 100 diseases, and charges $698, much less than the old blood tests cost, according to The New York Times (NYT) newspaper.


Balaji Srinivasan, the company's chief technology officer, told the NYT: 'The goal is not to maximise revenue but to bring the benefits to humanity. Nothing is more relevant than making sure your child doesn't die from a preventable disease'.


Feelings about Counsyl are mixed, according to quotes obtained by the NYT. Elena Ashkinadze, a prenatal genetic counsellor at the Robert Wood Johnson Medical School in New Jersey, said: 'As a genetic counsellor, I've been waiting for this for a really long time'. But Michael S Watson, executive director of the American College of Medical Genetics, said that many mutations are silent, meaning there is no risk to offspring. Couples might be needlessly worried.


Other experts told the NYT that a rise in identification of carriers would overwhelm the use of genetic counsellors. Also, the test looks for only 100 diseases - there are thousands of genetic conditions identified so far, which will not be tested for.

Related Articles

PET BioNews
Comment
7 September 2020 • 4 minutes read

What should we be testing for in sperm and egg donors?

by Sarah Norcross

This week, the Progress Educational Trust — in partnership with the Scottish Government — will be exploring the role of traditional and expanded carrier screening in assessing the suitability of sperm and egg donors...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 October 2012 • 2 minutes read

New genetic screening test for rare diseases to be launched in US

by Rosemary Paxman

A new genetic test screening for almost 450 rare childhood genetic diseases could be available in the US this year, reports the Beyond Batten Disease Foundation (BBDF)....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 October 2012 • 1 minute read

Survey suggests that Americans are willing to pay a premium for genetic tests

by Rosie Beauchamp

A recent study suggests American consumers would be prepared to pay on average up to $600 for a predictive genetic test where no direct treatment is available....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 September 2012 • 2 minutes read

Parental gene carrier testing could soon be available

by Vicki Kay

A new genetic test could lead to the elimination of hundreds of inherited diseases, US scientists claim....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
15 February 2010 • 3 minutes read

Back to the future

by Dr Adam Hedgecoe

The Counsyl 'Universal Genetic Test' has a distinctly 'retro' feel to it. With its focus on Mendelian disorders (i.e. classic genetic diseases like cystic fibrosis), many of the ethical issues raised by this new service are not new themselves, but rather present new challenges...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 January 2010 • 2 minutes read

deCODE is back

by Nishat Hyder

The pioneering genetics research company, deCODE, reemerged last week as a private company with new financial backing. Based in Reykjavik, Iceland, the original company deCODE Genetics, Inc led the way internationally in genetic testing and diagnostics for over a decade. With unique access to genetic information from Iceland's isolated population, the biotech firm has made important discoveries, such as identifying gene variants associated with common conditions ...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 November 2009 • 2 minutes read

Postmortem genetic testing recommended for sudden cardiac death families

by Marianne Kennedy

Postmortem genetic testing of people who have suffered sudden unexplained death (SUD) is a more effective and cost-efficient means of identifying genetic abnormalities that place surviving relatives at risk of fatal heart rhythm disturbances, a new study presented at the American Heart Association's annual meeting in Orlando, US, suggests....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Merck receives EU approval for new infertility drug

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856